Appleton Partners Inc Eli Lilly & CO Transaction History

Appleton Partners Inc

$1.36 Billion
Q3 2024

A detailed history of Appleton Partners Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Appleton Partners Inc holds 4,888 shares of LLY stock, worth $3.69 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

4,888

Previous 4,946 1.17%

Holding current value

$3.69 Million

Previous $4.48 Million 3.31%

% of portfolio

0.32%

Previous 0.34%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$772.14 - $960.02 $44,784 - $55,681	-58 Reduced 1.17%	4,888 $4.33 Million
Q2 2024 Jul 02, 2024	SELL	$724.87 - $909.04 $92,058 - $115,448	-127 Reduced 2.5%	4,946 $4.48 Million
Q1 2024 Apr 01, 2024	SELL	$592.2 - $792.28 $175,291 - $234,514	-296 Reduced 5.51%	5,073 $3.95 Million
Q4 2023 Jan 02, 2024	SELL	$525.19 - $619.13 $55,144 - $65,008	-105 Reduced 1.92%	5,369 $3.13 Million
Q3 2023 Oct 03, 2023	SELL	$434.7 - $599.3 $226,913 - $312,834	-522 Reduced 8.71%	5,474 $2.94 Million
Q2 2023 Jul 10, 2023	SELL	$350.74 - $468.98 $24,551 - $32,828	-70 Reduced 1.15%	5,996 $2.81 Million
Q1 2023 Apr 10, 2023	SELL	$310.63 - $364.82 $46,905 - $55,087	-151 Reduced 2.43%	6,066 $2.08 Million
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $96,786 - $112,775	-301 Reduced 4.62%	6,217 $2.27 Million
Q3 2022 Oct 27, 2022	SELL	$296.48 - $337.87 $29,648 - $33,787	-100 Reduced 1.51%	6,518 $2.11 Million
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $35,398 - $41,563	127 Added 1.96%	6,618 $2.15 Million
Q1 2022 Apr 05, 2022	SELL	$234.69 - $291.66 $34,030 - $42,290	-145 Reduced 2.19%	6,491 $1.86 Million
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $16,863 - $20,928	-75 Reduced 1.12%	6,636 $1.83 Million
Q3 2021 Oct 14, 2021	SELL	$221.6 - $272.71 $52,076 - $64,086	-235 Reduced 3.38%	6,711 $1.55 Million
Q2 2021 Jul 07, 2021	BUY	$180.55 - $233.54 $129,996 - $168,148	720 Added 11.56%	6,946 $1.59 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $1,643 - $2,127	-10 Reduced 0.16%	6,226 $1.16 Million
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $20,873 - $27,620	160 Added 2.63%	6,236 $1.05 Million
Q3 2020 Oct 14, 2020	SELL	$146.22 - $169.13 $21,933 - $25,369	-150 Reduced 2.41%	6,076 $899,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $27,283 - $32,836	-200 Reduced 3.11%	6,226 $1.02 Million
Q1 2020 May 04, 2020	BUY	$119.05 - $147.35 $192,861 - $238,707	1,620 Added 33.71%	6,426 $891,000
Q4 2019 Jan 13, 2020	SELL	$106.92 - $132.43 $55,384 - $68,598	-518 Reduced 9.73%	4,806 $632,000
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $25,481 - $29,743	230 Added 4.52%	5,324 $590,000
Q1 2019 Apr 17, 2019	SELL	$111.31 - $131.02 $16,139 - $18,997	-145 Reduced 2.77%	5,094 $661,000
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $42,042 - $47,100	-397 Reduced 7.04%	5,239 $606,000
Q3 2018 Oct 09, 2018	SELL	$85.86 - $107.31 $38,379 - $47,967	-447 Reduced 7.35%	5,636 $605,000
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $66,464 - $76,280	-878 Reduced 12.61%	6,083 $519,000
Q1 2018 Apr 11, 2018	BUY	$74.21 - $87.6 $4,823 - $5,694	65 Added 0.94%	6,961 $539,000
Q4 2017 Jan 12, 2018	BUY	$81.94 - $87.89 $11,061 - $11,865	135 Added 2.0%	6,896 $582,000
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $521,070 - $578,335	6,761	6,761 $578,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.

Account

Appleton Partners Inc Eli Lilly & CO Transaction History